Healthcare stays broadly healthy — the same twelve names that carried a clean uptrend two scans ago still do — but the cut's overbought edge shifted names: $ABT cooled hard off its overbought squeeze (RSI 77.8 to 59.6) while $VEEV took its place as the cut's most extended name at RSI 74.9, still down 12.2% below its year-ago alpha despite the strength. $HROW is the new concern, dropping 12.9 RSI points into the oversold band and crossing below its 200-day for the first time this scan has tracked. $ZTS remains the cut's deepest breakdown by a wide margin, and $ISRG continues its relapse for a fourth straight scan.

Data as-of the 2026-08-28 close (Friday's settled session) — every name in this cut carries a fresh bar this scan.

Source: healthcare.json (the broader universe, not the narrower healthcare-scan.json cut — consistent with the prior scan). Prior scan: 2026-08-22-healthcare-scan.

The cohort's core uptrend group is unchanged from two scans ago: $BIIB, $LLY, $JNJ, $GH, $GILD, $VRTX, $XLV, $DXCM, $PFE, $AMGN, $TMO, and $MRK all remain above their 200-day average with a strongly positive year-over-year return, the same twelve names that anchored the "broadly strong" read then. What moved is which name carries the cohort's overbought-but-weak-trend flag. Two scans ago it was $ABT, extended on RSI (77.8) despite a negative year and badly lagging alpha. This scan $ABT cooled sharply — RSI down to 59.6, no longer extended — while $VEEV took over the pattern: RSI jumped from 69.7 to 74.9, the cut's highest print, on an 11.5% weekly gain, yet its year-over-year return is barely positive (+1.6%) and its alpha remains badly negative (-18.3). Read $VEEV's current strength as a squeeze inside a still-weak trend, not confirmation of a healthy one.

$HROW is this scan's new concern. It dropped from RSI 52.4 to 39.5 — a 12.9-point decline on an 8.9% weekly drop — and crossed below its 200-day average for the first time (now -9.8%, versus -0.6% two scans ago), with its year-over-year return also turning negative (-4.4%). That's a meaningful deterioration from "testing 200-day" to a genuine breakdown signature, worth tracking closely.

$ZTS remains the cleanest long-trend breakdown in the cut, and it's essentially unchanged at the worst level: down 50.0% over the past year, 25.7% below its 200-day average, with an alpha of -69.9. RSI sits at 53.3 — still mid-range, still not obviously alarming on its own — which is exactly why the long-trend check matters here more than anywhere else in this cut. $ISRG continues the relapse pattern flagged across the past three scans, now a fourth straight scan below its 200-day (-20.5%) with a negative year-over-year return (-21.4%), both numbers slightly worse than two scans ago.

$CVS remains in the oversold band (37.9, up modestly from 34.1) but continues to pass the long-trend test cleanly: above its 200-day with a positive year-over-year return (+29.0%) and positive alpha. $UNH is the weakest print among the intact names (RSI 42.3) but also clears the test (+30.0% on the year, above its 200-day). Read those two as deep pullbacks inside intact trends, the opposite read from $ZTS, $ISRG, $SYK, and now $HROW despite superficially similar or even higher RSI levels.

• $HROW dropped into the oversold band and crossed below its 200-day. RSI 52.4 → 39.5 (-12.9), price down 8.9% for the week — the first time this scan has tracked it below its 200-day, with the year-over-year return also turning negative.
• $ABT cooled off its overbought squeeze. RSI 77.8 → 59.6 (-18.2), no longer extended, though the underlying trend is still weak (1-year return -14.4%).
• $VEEV took over the cut's overbought-but-weak-trend spot. RSI 69.7 → 74.9 (+5.2), now the cut's highest print, still barely positive on the year with negative alpha.
• $MRK cooled from its tied-highest print. RSI 77.8 → 62.5 (-15.3), still up 78% over the year.
• $TMO cooled from extended. RSI 74.6 → 66.2 (-8.4), still up 27% over the year.
• $CVS recovered slightly within the oversold band. RSI 34.1 → 37.9 (+3.8), still above its 200-day with a positive year.
• $ISRG continues its relapse for a fourth straight scan — 1-year return -19.4% → -21.4%, vs-200-day -19.9% → -20.5%, both slightly worse.
• $ZTS remains essentially unchanged at the cut's deepest breakdown — -50.1% → -50.0% on the year, still the widest gap to its 200-day in the cut.
• No stale bars this scan — every name carries a fresh 2026-08-28 close.
• Universe unchanged. Same 22 tickers as the prior scan.

RSI measures how stretched a stock is over the past 14 sessions — under 30 signals oversold, over 70 signals overbought/extended. vs SMA20 is the price gap to the 20-day average. 1Y% and vs SMA200 are the two numbers that separate a genuine breakdown from a pullback: $CVS and $UNH both look weak on RSI this scan but are above their 200-day with a positive year — deep pullbacks, not breakdowns. $ZTS, $ISRG, $SYK, and now $HROW are below their 200-day with a negative year — genuine breakdowns, regardless of a mid-range RSI. $VEEV is the trickiest read this scan: extended on RSI (74.9) but barely positive on the year with a negative alpha — don't let the short-term strength stand in for the long-trend read.

None.

$CVS (37.9), $HROW (39.5) — two names, up from one two scans ago. $CVS is above its 200-day with a positive year, a deep pullback rather than a breakdown; $HROW newly failed that test, now below its 200-day with a negative year.

• Genuine breakdown (below 200-day, negative 1-year): $SYK, $ISRG, $ZTS — three names; $ZTS is the deepest of the group by a wide margin, essentially unchanged from the prior scan.
• Flat 1-year despite mid-range RSI: $MDT — technically above its 200-day but flat on the year with weak alpha.
• Overbought but long-trend weak (the scan's key nuance): $VEEV, $ABT — $VEEV is now extended on RSI with a barely-positive year; $ABT cooled off its own extension but the underlying trend is still weak.
• Extreme, high-variance move: $MRNA — up 464% over the year, a distinct situation from the rest of the cut.
• Genuinely healthy uptrend: $BIIB, $LLY, $JNJ, $GH, $GILD, $VRTX, $XLV, $DXCM, $PFE, $AMGN, $TMO, $MRK — twelve names, the bulk of the cut, all above their 200-day with a strongly positive year, unchanged from the prior scan.
• Deep pullback but intact: $CVS, $UNH — weak RSI this scan, but above the 200-day with a positive year.

• $VEEV is now the cut's most overbought name yet barely positive on the year — does the trend catch up to the price, or does the RSI cool back down first, the way $ABT's did this scan?
• $HROW newly crossed below its 200-day — does it stabilize, or does this become the next multi-scan relapse pattern like $ISRG's?
• $ISRG is below its 200-day for a fourth straight scan — does the relapse finally break, or continue a fifth time?
• $ZTS remains 26% below its 200-day and down 50% over the year with no confirmed floor — does it find one, or does the breakdown deepen further?

• Tape data (price/RSI/SMA/returns): full-scan pre-computed summaries as of the 2026-08-28 close — healthcare.
• Prior scan for comparison: 2026-08-22-healthcare-scan.